November 1, 2016 – 14:00 GMT

MPP Head of Policy Esteban Burrone participates as a panellist in a webinar: An Introduction to Accessing Generic Hepatitis C Medicines.

Past events

The Medicines Patent Pool Publishes Peer-Reviewed Paper on Forecasting Antiretrovirals in Low- and Middle-Income Countries (LMICs)

Read the article

MPP’s summer newsletter

The MPP publishes its July 2016 newsletter featuring an update on its last six months of progress.

The New York Times – New strategies to fight AIDS

Letter to the editor from MPP’s Executive Director

Voluntary Patent Pooling: Encouraging Rapid Scale-Up of Medicines for Resource-Limited Countries

Read a blog post by Greg Perry, MPP’s Executive Director

Medicines Patent Pool statement, 69th World Health Assembly

Read full statement


Generics Bulletin: “Medicines Patent Pool has potential for wider scope”

Read the article

MPP Submission to the UN High-Level Panel on Access to Medicines

Read the MPP submission.

MPP Newsletter – January 2016

One licence for a HCV medicine, two new disease areas, four new board members, $120 million in savings: check out MPP’s January newsletter for an update on top initiatives in Q3/Q4 2015.

Global Innovative Financing for the Next Decade

Greg Perry and Philippe Douste-Blazy in Global Health and Diplomacy Magazine

New agreements for TAF signed with Lupin and Micro Labs

View our sub-licensees section